CRITEO®

Tablet, 50 mg
RxActive license

Active substance (INN)

vildagliptin

Pharmaceutical form

Pharmaceutical formTablet
Strength50 mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d., Serbia
Therapeutic groupAlimentary tract and metabolism (A10BH02)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateMay 30, 2023

Analogs in Montenegro

6

Other medicines with the same active substance

AGNISRx
Tablet, 50mglijekovi i kozmetika d.d.
CRITEO DUORx
Film-coated tablet, 50mg + 850mgHemofarm a.d.
CRITEO DUORx
Film-coated tablet, 50mg + 1000mgHemofarm a.d.
CRITEO®Rx
Tablet, 50mgHemofarm a.d.
EUCREASRx
Film-coated tablet, 50mg + 1000mgNovartis Pharma GmbH
GALVUSRx
Tablet, 50mgNovartis Farmaceutica S.A.
Source: CInMED register